Venus Concept Inc. (NASDAQ:VERO – Get Free Report) was the recipient of a large growth in short interest in the month of October. As of October 31st, there was short interest totalling 1,450,000 shares, a growth of 1,956.7% from the October 15th total of 70,500 shares. Based on an average daily trading volume, of 1,690,000 shares, the days-to-cover ratio is currently 0.9 days. Approximately 35.1% of the shares of the company are short sold.
Insider Buying and Selling at Venus Concept
In other Venus Concept news, major shareholder Michael Willingham Masters sold 94,553 shares of the company’s stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $0.53, for a total value of $50,113.09. Following the sale, the insider now directly owns 17,059 shares in the company, valued at $9,041.27. This represents a 84.72 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 57.98% of the company’s stock.
Institutional Investors Weigh In On Venus Concept
A hedge fund recently raised its stake in Venus Concept stock. Masters Capital Management LLC grew its stake in Venus Concept Inc. (NASDAQ:VERO – Free Report) by 100.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 666,702 shares of the company’s stock after acquiring an additional 333,366 shares during the period. Masters Capital Management LLC owned 10.49% of Venus Concept worth $522,000 as of its most recent filing with the Securities and Exchange Commission. 87.41% of the stock is owned by institutional investors and hedge funds.
Venus Concept Price Performance
Venus Concept (NASDAQ:VERO – Get Free Report) last posted its quarterly earnings data on Tuesday, August 13th. The company reported ($1.39) earnings per share for the quarter. The firm had revenue of $16.58 million for the quarter. On average, analysts anticipate that Venus Concept will post -6.37 EPS for the current year.
About Venus Concept
Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.
See Also
- Five stocks we like better than Venus Concept
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- What is the Shanghai Stock Exchange Composite Index?
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- Pros And Cons Of Monthly Dividend Stocks
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Venus Concept Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venus Concept and related companies with MarketBeat.com's FREE daily email newsletter.